Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 101–140 of 140 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06374602	Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer	recruiting	Phase 2	20	Saint Petersburg State University, RussiaOTHER	1	Sep 5, 2025	clinicaltrials
NCT06359847	Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer	recruiting	Phase 2	60	Beijing Scitech-Mq Pharmaceuticals LimitedINDUSTRY	1	Aug 24, 2025	clinicaltrials